Phio Pharmaceuticals PHIO
NASDAQ PHIO
$0.91 +0.02 (+2.80%)
As of: Oct 21, 2026 · 3:59 PM EDT

Phio Pharmaceuticals (PHIO) Debt Ratio (2020)

Updated

Phio Pharmaceuticals' (PHIO) Debt Ratio was 0.01 for Q4 2020, up 15.9% from the prior quarter.

Analysis

Phio Pharmaceuticals (PHIO) Debt Ratio (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Phio Pharmaceuticals 10.57 Mn -51.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 0.01
Sep 30, 2020 0.01
Jun 30, 2020 0.01
API Access

Phio Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=PHIO&period=max&api_key=YOUR_API_KEY